BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Tesla
TSLA
|
+$488M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$271M |
| 5 |
Abbott
ABT
|
+$253M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Visa
V
|
+$487M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$441M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$252M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Financials | 12.01% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Healthcare | 8.94% |
| 5 | Communication Services | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Comp X International
CIX
$282M
| $12.9K | ﹤0.01% |
619
-569
| -48% | -$11.8K |
|
2927
Wrap Technologies
WRAP
$86.9M
| $12.8K | ﹤0.01% |
1,629
-72
| -4% | -$565 |
|
2928
Transcat
TRNS
$705M
| $12.7K | ﹤0.01% |
225
-590
| -72% | -$33.3K |
|
|
HARP
2929
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $12.7K | ﹤0.01% |
92
-78
| -46% | -$10.8K |
|
2930
Lexicon Pharmaceuticals
LXRX
$392M
| $12.7K | ﹤0.01% |
2,757
-4,041
| -59% | -$18.5K |
|
2931
Full House Resorts
FLL
$120M
| $12.5K | ﹤0.01% |
+1,260
| New | +$12.5K |
|
2932
Franklin Financial Services
FRAF
$212M
| $12.5K | ﹤0.01% |
390
-1,567
| -80% | -$50.1K |
|
|
TBHC
2933
The Brand House Collective, Inc. Common Stock
TBHC
$44.2M
| $12.4K | ﹤0.01% |
+540
| New | +$12.4K |
|
2934
Cue Biopharma
CUE
$58.6M
| $12.3K | ﹤0.01% |
1,058
-2,650
| -71% | -$30.9K |
|
2935
ESSA Pharma
EPIX
$9.7M
| $12.3K | ﹤0.01% |
+431
| New | +$12.3K |
|
2936
iRadimed
IRMD
$910M
| $12.3K | ﹤0.01% |
418
-320
| -43% | -$9.41K |
|
2937
Savara
SVRA
$662M
| $12.3K | ﹤0.01% |
7,225
-12,411
| -63% | -$21.1K |
|
2938
Rekor Systems
REKR
$140M
| $12.3K | ﹤0.01% |
+1,208
| New | +$12.3K |
|
|
AMPE
2939
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $12.2K | ﹤0.01% |
+24
| New | +$12.2K |
|
2940
First Business Financial Services
FBIZ
$431M
| $12.2K | ﹤0.01% |
450
-3,696
| -89% | -$100K |
|
2941
KALA BIO
KALA
$107M
| $12.1K | ﹤0.01% |
46
-57
| -55% | -$15K |
|
|
CVLY
2942
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $12.1K | ﹤0.01% |
603
-3,704
| -86% | -$74.2K |
|
2943
Wave Life Sciences
WVE
$1.18B
| $12K | ﹤0.01% |
1,805
-2,389
| -57% | -$15.9K |
|
2944
Puma Biotechnology
PBYI
$229M
| $12K | ﹤0.01% |
1,309
-6,308
| -83% | -$57.9K |
|
2945
BayCom
BCML
$329M
| $12K | ﹤0.01% |
669
-3,419
| -84% | -$61.4K |
|
|
EXPR
2946
DELISTED
Express, Inc.
EXPR
| $11.9K | ﹤0.01% |
92
-1,381
| -94% | -$179K |
|
2947
CB Financial Services
CBFV
$166M
| $11.9K | ﹤0.01% |
537
-2,107
| -80% | -$46.7K |
|
2948
UroGen Pharma
URGN
$884M
| $11.8K | ﹤0.01% |
774
-3,665
| -83% | -$56K |
|
2949
SIGA Technologies
SIGA
$624M
| $11.8K | ﹤0.01% |
1,872
-5,606
| -75% | -$35.2K |
|
2950
Riverview Bancorp
RVSB
$101M
| $11.7K | ﹤0.01% |
1,657
-9,198
| -85% | -$65.2K |
|